…marker improvements over riociguat in inoperable CTEPH, whereas riociguat enhances cardiac output. A patient-specific approach considerin…
4articles mentioning drugs
15drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: riociguat ×
riociguat
This drug is selected. Its supporting articles are shown below.
Articles mentioning riociguat
4 articles · page 1 of 1riociguatBPACochrane CENTRAL
PDE5iriociguatERAendothelin receptor antagonistRoyal Papworth HospitalCTEPHchronic thromboembolic PH (CTEPH)Pulmonary hypertensionBPA
…triuretic peptide (−67% vs −21% vs −32%, p=0.004) compared with PDE5i monotherapy and riociguat monotherapy. These differences persis…
riociguatPDE5iERANT-proBNPendothelin receptor antagonistsRoyal Papworth HospitalCTEPHchronic thromboembolic pulmonary hypertension
…herapy, 67 received PDE5i and ERA dual therapy, and 49 received riociguat monotherapy. Patients with more severe baseline haemodynamic da…
sildenafildiltiazemriociguatmacitentanlung transplantationPulmonary Veno-Occlusive DiseasePAH
…ommenced initially on diltiazem and with subsequent addition of sildenafil. At 4-month follow-up, CardioMEMS was implanted and macitentan …